NELARABINE
PURINE ANALOGUES · T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ·+1
X-GEN PHARMACEU
Drug class
Purine Analogues
Purine analogues are a class of antimetabolite medications chemically structured to mimic endogenous purine nucleosides and bases, such as adenine and guanine. Read more about Purine Analogues
75 drugs in this class 47 manufacturers
Drugs in Purine Analogues
CLADRIBINE
PURINE ANALOGUES · HAIRY CELL LEUKEMIA
HISUN-NOVAPLUS
AZATHIOPRINE
PURINE ANALOGUES · RHEUMATOID ARTHRITIS ·+1
PD-RX PHARM
AZATHIOPRINE
PURINE ANALOGUES · RHEUMATOID ARTHRITIS ·+1
AHP
NELARABINE
PURINE ANALOGUES · T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ·+1
ZYDUS USA-NOVAP
NELARABINE
PURINE ANALOGUES · T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ·+1
Amneal Pharmaceuticals
CLADRIBINE
PURINE ANALOGUES · HAIRY CELL LEUKEMIA
Hikma Pharmaceuticals USA
ARRANON (nelarabine)
PURINE ANALOGUES · T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ·+1
SANDOZ INC.
AZATHIOPRINE
PURINE ANALOGUES · RHEUMATOID ARTHRITIS ·+1
GSMS, INC.
Filter & compare in the drug finder →
Opens the drug finder with Purine Analogues preselected. Add indication or manufacturer filters there.
Purine analogues are a class of antimetabolite medications chemically structured to mimic endogenous purine nucleosides and bases, such as adenine and guanine.
Once incorporated into target cells and metabolically activated, they disrupt cellular proliferation by competing with natural substrates, inhibiting key enzymes in purine biosynthesis and DNA replication, and causing DNA strand termination or damage.
Therapeutically, these agents are primarily indicated for the treatment of hematologic malignancies, including acute leukemias, chronic lymphocytic leukemia, and hairy cell leukemia, as well as selected autoimmune conditions like multiple sclerosis and inflammatory bowel disease.
-
fda.gov
Purine analogues are a class of antimetabolite medications chemically structured to mimic endogenous purine nucleosides and bases, such as adenine and guanine Once incorporated into target cells and metabolically activated, they disrupt cellular proliferation by competing with natural substrates, inhibiting key enzymes in purine biosynthesis and DNA replication, and causing DNA strand termination or damage
-
fda.gov
Purine analogues are a class of antimetabolite medications chemically structured to mimic endogenous purine nucleosides and bases, such as adenine and guanine Once incorporated into target cells and metabolically activated, they disrupt cellular proliferation by competing with natural substrates, inhibiting key enzymes in purine biosynthesis and DNA replication, and causing DNA strand termination or damage Therapeutically, these agents are primarily indicated for the treatment of hematologic mal...
-
fda.gov
Once incorporated into target cells and metabolically activated, they disrupt cellular proliferation by competing with natural substrates, inhibiting key enzymes in purine biosynthesis and DNA replication, and causing DNA strand termination or damage Therapeutically, these agents are primarily indicated for the treatment of hematologic malignancies, including acute leukemias, chronic lymphocytic leukemia, and hairy cell leukemia, as well as selected autoimmune conditions like multiple sclerosis ...
-
fda.gov
Therapeutically, these agents are primarily indicated for the treatment of hematologic malignancies, including acute leukemias, chronic lymphocytic leukemia, and hairy cell leukemia, as well as selected autoimmune conditions like multiple sclerosis and inflammatory bowel disease
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.